BridgeBio Pharma Cash Flow Statement (2018-2026) | BBIO

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-199.51M-174.56M-188.09M-194.27M-100.50M-146.52M-158.00M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-267.39M-122.26M-183.76M-184.94M-194.59M-120.03M
Share-based Compensation (Quarter)
3.75M16.13M25.84M0.97M0.06M18.66M22.58M0.19M0.12M27.23M30.83M0.54M21.45M27.13M1.40M25.88M37.34M31.66M-84.16M4.07M
Gains from Investment Securities (Quarter)
1.12M-0.66M0.74M0.85M10.22M0.06M0.12M-0.11M-0.11M0.27M-1.04M
Asset Writedowns and Impairment (Quarter)
-3.30M12.65M0.07M
Cash from Operations (Quarter)
-91.71M-121.56M-133.90M-160.63M-30.45M-135.16M-93.24M-144.32M-113.35M-145.23M-124.82M-219.54M74.70M-180.57M-195.33M-199.24M-80.68M-109.57M-56.42M-197.28M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.40M1.39M1.75M2.48M1.90M2.09M2.10M2.34M2.24M2.14M2.18M2.02M1.67M1.72M10.36M25.64M27.46M
Amortization of Deferred Charges (Quarter)
0.49M2.06M0.99M0.49M1.96M1.82M
Depreciation & Amortization (CF) (Quarter)
3.49M0.27M1.53M1.88M1.58M1.65M1.66M1.63M1.64M1.64M1.58M1.60M1.57M1.54M1.37M1.28M1.32M1.40M1.44M1.19M
Change in Working Capital
Change in Receivables (Quarter)
233.74M-234.83M-0.18M4.24M110.54M-38.40M39.65M22.93M65.78M
Change in Inventory (Quarter)
3.19M13.39M6.77M1.95M7.05M
Change in Account Payables (Quarter)
11.23M-11.66M1.47M-1.81M-1.28M1.36M1.38M-3.80M-0.30M0.69M6.18M-5.93M14.79M-3.60M-3.75M17.57M-1.05M-7.43M17.52M-7.17M
Change in Accured Expenses (Quarter)
6.14M-4.23M15.79M-2.88M10.67M-6.54M-3.60M-6.37M-4.70M6.92M11.96M-1.26M-7.12M1.77M23.60M2.94M-18.58M18.85M74.60M4.62M
Other Working Capital Changes (Quarter)
0.05M5.14M-3.74M-7.90M-0.79M-1.40M2.42M0.48M-3.67M-1.28M-0.97M24.02M-17.52M14.07M1.30M0.49M-0.31M17.35M-18.64M1.79M
Investing Activities
Capital Expenditures (Quarter)
2.46M-1.80M10.80M0.75M2.51M-3.20M4.76M0.01M0.43M-0.25M-0.09M0.69M-0.62M0.20M0.01M0.01M1.08M0.07M
Sales of Property, Plant and Equipment (Quarter)
10.00M
Divestments (Quarter)
29.41M25.68M2.30M
Change in Acquisitions & Divestments (Quarter)
139.73M-234.19M375.46M6.67M3.04M443.11M26.87M18.00M23.55M39.41M29.59M63.23M31.77M10.00M
Cash from Investing Activities (Quarter)
0.46M58.97M21.80M138.62M149.70M146.86M17.96M12.30M4.12M37.68M-0.07M22.75M3.04M38.23M-3.24M-1.59M-13.00M4.46M-14.35M-42.73M
Financing Activities
Other financing activities (Quarter)
-5.81M2.17M-3.82M1.12M-1.12M2.56M0.19M1.62M1.59M-4.20M0.54M0.24M0.03M-0.81M0.80M2.44M11.29M-12.37M5.47M
Cash from Financing Activities (Quarter)
-1.39M-135.46M325.38M-0.16M-20.80M1.45M6.38M150.25M-1.23M307.04M-4.52M279.55M-5.73M0.71M473.93M60.33M302.04M-0.89M-2.18M549.89M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
4.90M143.02M1.03M241.30M-0.45M315.25M38.16M-0.02M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Change in Cash (Quarter)
-92.65M-198.05M213.29M-22.17M98.45M13.14M-68.90M18.23M-110.47M199.50M-129.41M82.76M72.01M-141.63M275.37M-140.50M208.36M-106.00M-72.96M309.88M
Free Cash Flow (Quarter)
-94.17M-119.76M-144.69M-161.38M-32.96M-131.96M-98.00M-144.33M-113.78M-144.98M-124.73M-220.23M75.33M-180.77M-195.33M-199.24M-80.68M-109.59M-57.51M-197.35M
Net Cash Flow (Quarter)
-92.65M-198.05M213.29M-22.17M98.45M13.14M-68.90M18.23M-110.47M199.50M-129.41M82.76M72.01M-141.63M275.37M-140.50M208.36M-106.00M-72.96M309.88M